ZTS株価 $76.03 · 時価総額 $34.0bn
Zoetis Inc.
Pharmaceutical Preparations| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $8.5bn | $9.3bn | $9.5bn |
| 成長率 | — | 8.3% | 2.3% |
| 総利益 | $6.0bn | $6.5bn | $6.8bn |
| 総利益率 | 70.0% | 70.6% | 71.8% |
| 販管費 | $2.2bn | $2.3bn | $2.4bn |
| 販管費率 | 25.2% | 25.0% | 25.1% |
| 営利 | — | — | — |
| 営利率 | — | — | — |
| 純利益 | $2.3bn | $2.5bn | $2.7bn |
| PSR | 3.98x | 3.68x | 3.60x |
| PGPR | 5.7x | 5.2x | 5.0x |
| PER | 14.5x | 13.7x | 12.7x |
| PBR | 6.81x | 7.14x | 10.22x |
| ネットキャッシュ | $-5.0bn | $-5.0bn | $-7.5bn |
| EV/EBITDA | — | — | — |
| Rule of 40 | — | — | — |
| セールス効率 | — | 331.7% | 440.0% |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
